Chopas James George

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
16 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Chopas James George's trades of Apellis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-22
S Sale
87,175 -10.0%
434.16
US$2,616,316 		87,175 -10.0% 434.16 US$2,616,316
2026-01-22 2026-01-22
PrS Proposed sale
7,362
127.26
US$1,132,638 		7,362 127.26 US$1,132,638
2026-01-21 2026-01-20
S Sale
88,542 +18.1%
78.25
US$2,923,989 		88,542 +18.1% 78.25 US$2,923,989
2026-01-20 2026-01-20
PrS Proposed sale
726
19.79
US$14,370 		726 19.79 US$14,370
2026-01-15 2026-01-13
S Sale
873 -1.6%
22.19
US$19,369 		873 -1.6% 22.19 US$19,369
2026-01-13 2026-01-13
PrS Proposed sale
873
22.19
US$19,369 		873 22.19 US$19,369
2025-09-17 2025-09-15
S Sale
189 -0.4%
24.19
US$4,572 		189 -0.4% 24.19 US$4,572
2025-09-15 2025-09-15
PrS Proposed sale
189
24.19
US$4,572 		189 24.19 US$4,572
2025-09-03 2025-09-02
S Sale
548 -1.0%
28.08
US$15,386 		548 -1.0% 28.08 US$15,386
2025-09-02 2025-09-02
PrS Proposed sale
548
28.08
US$15,386 		548 28.08 US$15,386
2025-03-18 2025-03-17
S Sale
183 -0.4%
24.82
US$4,543 		183 -0.4% 24.82 US$4,543
2025-03-17 2025-03-17
PrS Proposed sale
183
24.82
US$4,543 		183 24.82 US$4,543
2025-01-23 2025-01-22
S Sale
1,096 -2.2%
30.43
US$33,346 		1,096 -2.2% 30.43 US$33,346
2025-01-22 2025-01-22
PrS Proposed sale
1,096
30.43
US$33,346 		1,096 30.43 US$33,346
2025-01-21 2025-01-17
S Sale
715 -1.9%
29.96
US$21,420 		715 -1.9% 29.96 US$21,420
2025-01-17 2025-01-17
PrS Proposed sale
715
29.96
US$21,420 		715 29.96 US$21,420
2025-01-14 2025-01-13
S Sale
783 -2.1%
28.70
US$22,474 		783 -2.1% 28.70 US$22,474
2025-01-13 2025-01-13
PrS Proposed sale
798
28.70
US$22,900 		798 28.70 US$22,900
2024-09-17 2024-09-16
S Sale
192 -0.5%
36.21
US$6,952 		192 -0.5% 36.21 US$6,952
2024-09-16 2024-09-16
PrS Proposed sale
192
36.21
US$6,952 		192 36.21 US$6,952
2024-09-04 2024-09-03
S Sale
550 -1.4%
39.49
US$21,720 		550 -1.4% 39.49 US$21,720
2024-09-03 2024-09-03
PrS Proposed sale
550
39.49
US$21,720 		550 39.49 US$21,720
2024-03-18 2024-03-15
S Sale
184 -0.5%
56.46
US$10,389 		184 -0.5% 56.46 US$10,389
2024-03-15 2024-03-15
PrS Proposed sale
184
56.46
US$10,389 		184 56.46 US$10,389
2024-01-23 2024-01-22
S Sale
1,061 -2.6%
65.00
US$68,961 		1,061 -2.6% 65.00 US$68,961
2024-01-22 2024-01-22
PrS Proposed sale
1,061
65.00
US$68,961 		1,061 65.00 US$68,961
2024-01-17 2024-01-16
S Sale
864 -2.1%
66.81
US$57,723 		864 -2.1% 66.81 US$57,723
2024-01-16 2024-01-16
PrS Proposed sale
864
66.81
US$57,723 		864 66.81 US$57,723
2023-10-24 2023-10-23
S Sale
132 -0.4%
46.04
US$6,077 		132 -0.4% 46.04 US$6,077
2023-10-23 2023-10-23
PrS Proposed sale
132
46.04
US$6,077 		132 46.04 US$6,077
2023-09-01 2023-08-31
S Sale
551 -1.8%
41.23
US$22,716 		551 -1.8% 41.23 US$22,716
2023-08-31 2023-08-31
PrS Proposed sale
551
41.23
US$22,716 		551 41.23 US$22,716
2021-03-09 2021-03-05
PlS Planned sale
370 -5.2%
20.88
US$7,726 		370 -5.2% 20.88 US$7,726